Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Alopecia Areata”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06018428
What this trial is testing

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Who this might be right for
Alopecia Areata
Q32 Bio Inc. 75
Not applicableStudy completedNCT02494297
What this trial is testing

DUS on the Prescribing Indications for CPA/EE in 5 European Countries

Who this might be right for
HirsutismAndrogenetic AlopeciaSevere Anemia+2 more
Center for Epidemiology and Health Research, Germany 1,597
Testing effectiveness (Phase 2)Study completedNCT02974868
What this trial is testing

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 142
Post-approval studies (Phase 4)Study completedNCT01167946
What this trial is testing

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Who this might be right for
Alopecia TotalisAlopecia UniversalisOphiasic Alopecia
King Saud University 42
Testing effectiveness (Phase 2)Study completedNCT03941548
What this trial is testing

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Concert Pharmaceuticals 66
Not applicableStudy completedNCT00167102
What this trial is testing

Alefacept in Patients With Severe Scalp Alopecia Areata

Who this might be right for
Alopecia Areata
University of Minnesota 45
Testing effectiveness (Phase 2)Study completedNCT02018042
What this trial is testing

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University 15
Early research (Phase 1)Looking for participantsNCT07205159
What this trial is testing

Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

Who this might be right for
Alopecia Areata
Forte Biosciences, Inc. 32
Not applicableStudy completedNCT02684123
What this trial is testing

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Icahn School of Medicine at Mount Sinai 30
Not applicableUnknownNCT04834102
What this trial is testing

COVID-19 Induced Telogen Effluvium

Who this might be right for
Covid19Telogen EffluviumSARS-CoV Infection+1 more
Istanbul Medeniyet University 200
Not applicableNot Yet RecruitingNCT07226531
What this trial is testing

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Who this might be right for
Alopecia Areata
Pfizer 300
Not applicableLooking for participantsNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Testing effectiveness (Phase 2)WithdrawnNCT00746980
What this trial is testing

Efalizumab in the Treatment of Alopecia, Phase II

Who this might be right for
Alopecia Totalis
Northwestern University
Large-scale testing (Phase 3)Looking for participantsNCT07029828
What this trial is testing

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Who this might be right for
Severe Alopecia Areata
Pfizer 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06562894
What this trial is testing

Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients

Who this might be right for
Severe Alopecia Areata
CSPC Ouyi Pharmaceutical Co., Ltd. 156
Not applicableStudy completedNCT04446429
What this trial is testing

Anti-Androgen Treatment for COVID-19

Who this might be right for
COVID-19SARS-CoV2Androgenetic Alopecia+3 more
Applied Biology, Inc. 268
Large-scale testing (Phase 3)Study completedNCT04518995
What this trial is testing

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)

Who this might be right for
Alopecia Areata
Concert Pharmaceuticals 706
Large-scale testing (Phase 3)Study completedNCT03899259
What this trial is testing

Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Eli Lilly and Company 606
Large-scale testing (Phase 3)Study completedNCT05051761
What this trial is testing

Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 425
Large-scale testing (Phase 3)Looking for participantsNCT07133308
What this trial is testing

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Sun Pharmaceutical Industries, Inc. 355
Load More Results